Lexaria Bioscience Corp.
LEXX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348362
No open-market purchases or sales by Lexaria Bioscience Corp. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $920.0K in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Lexaria Bioscience Corp. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 15 | 20 | +5 |
| Shares | 1.77M | 1.20M | −575.5K (−32.5%) |
| Value | $1.77M | $1.49M | −$276.1K (−15.6%) |
New holders (8)
Institutions that held Lexaria Bioscience Corp. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cowen and Company, LLC | 256,327 | $320.4K | 0.02% |
| Connective Capital Management, LLC | 60,000 | $75.0K | 0.06% |
| Citadel Advisors LLC | 29,561 | $37.0K | 0.00% |
| UBS Group AG | 4,532 | $5.67K | 0.00% |
| ADAR1 Capital Management, LLC | 1,626 | $2.03K | 0.00% |
| JPMorgan Chase & Co | 1,019 | $1.27K | 0.00% |
| Allworth Financial LP | 89 | $112 | 0.00% |
| Sound Income Strategies, LLC | 22 | $28 | 0.00% |
Sold out (3)
Institutions that held Lexaria Bioscience Corp. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Armistice Capital, LLC | 889,272 | $889.2K |
| Renaissance Technologies LLC | 12,900 | $13.0K |
| Two Sigma Securities, LLC | 10,545 | $10.5K |